Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia

• Xiangyu Zhao,
• Haotian Wu,
• Yifei Cheng,
• Zhengli Xu,
• Yuhong Chen,
• Yingjun Chang,
• Yu Wang,
• Xiaohui Zhang,
• Lanping Xu,
• Xiaojun Huang,
• Xiuyuan Hao

Affiliations

Xiangyu Zhao

1 Peking University People's Hospital, Peking University Institute of Hematology, Department of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Xicheng District, Beijing 100044, China

Haotian Wu

2 Peking University Health Science Center, Beijing 100191, China

Yifei Cheng

1 Peking University People's Hospital, Peking University Institute of Hematology, Department of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Xicheng District, Beijing 100044, China

Zhengli Xu

1 Peking University People's Hospital, Peking University Institute of Hematology, Department of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Xicheng District, Beijing 100044, China

Yuhong Chen

1 Peking University People's Hospital, Peking University Institute of Hematology, Department of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Xicheng District, Beijing 100044, China

Yingjun Chang

1 Peking University People's Hospital, Peking University Institute of Hematology, Department of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Xicheng District, Beijing 100044, China

Yu Wang

1 Peking University People's Hospital, Peking University Institute of Hematology, Department of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Xicheng District, Beijing 100044, China

Xiaohui Zhang

1 Peking University People's Hospital, Peking University Institute of Hematology, Department of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Xicheng District, Beijing 100044, China

Lanping Xu

1 Peking University People's Hospital, Peking University Institute of Hematology, Department of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Xicheng District, Beijing 100044, China

Xiaojun Huang

1 Peking University People's Hospital, Peking University Institute of Hematology, Department of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Xicheng District, Beijing 100044, China

Xiuyuan Hao